A new study by researchers at the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, has found that some ...

Sanofi and Regeneron’s Dupixent (dupilumab) could be set for its ninth US approval after the drug met all the primary and secondary endpoints in a Phase III study in allergic fungal rhinosinusitis ...

Kerala has published the 2024 State Antibiogram (AMR Surveillance Report), presenting an assessment of antimicrobial resistance (AMR) trends and the state’s strategy to curb misuse of antibiotics. <br ...

Avocados, a beloved kitchen staple, are notoriously delicate and ripen quickly. Understanding their biological nature as ...

Fungi in cities are adapting to rising temperatures, a shift that could increase their chances of surviving in the human body ...

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics through its boron chemistry platform, today announced a collaboration agreement with the ...

In 2019, the global neutropenia treatment market was valued at a staggering $12,602.5 million. This figure encapsulates the substantial demand for innovative therapies aimed at combating ...

LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the ...

Research into treatment for Valley fever, a fungal disease, continues, as does work on a vaccine to prevent it.

A pathologist died at Wythenshawe Hospital after he was given the wrong drug, causing an overdose, a coroner has said ...

Ultimately, aging is a journey. By understanding our bodies—even down to their unique scents—we can navigate this phase with ...

Every mind-bending molecule in nature has an evolutionary origin; a defense against being eaten, a lure for pollinators, or ...